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ABSTRACT
Objective: This study aimed to compare the bronchorelaxation effect of the methanol extract, hexane fraction, ethyl acetate fraction, and methanol 
fraction of Coptosapelta flavescens Korth. roots (CFRs) on the isolated bronchial rings of guinea pig.
Methods: Research design was experimental in which a 4-mm long bronchus of a male guinea pig was kept in an isolated organ bath containing 
Krebs-Henseleit solution at 37°C, pH 7.4, and flooded with carbogen gas. The bronchial ring was precontracted with methacholine and then given six 
doses of C. flavescens Korth. root’s methanol extract (MECFR) solution cumulatively. The extract’s solvent 10% dimethyl sulfoxide ethanol was used 
as negative control. This procedure was then repeated using CFRs hexane fraction (HFCFR) solution, CFRs ethyl acetate fraction (EAFCFR), and CFRs 
methanol fraction (MFCFR).
Results: The bronchorelaxation effect of MECFR, MFCFR, EAFCFR, and HFCFR is shown by their dose-response curves (DRCs) which are significantly 
different compared with the extracts solvent’s DRC. The maximal efficacy (Emax) of MFCFR was the same (p>0.05) as the MECFRs Emax, but the EAFCFRs 
and HFCFRs Emax were smaller (p<0.05) than the MECFRs Emax.
Conclusion: The bronchorelaxation effect of the MECFR on the guinea pig’s bronchial ring is similar to the CFRs methanol fraction, and is stronger 
than the CFRs ethyl acetate fraction and CFRs hexane fraction.
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INTRODUCTION
Coptosapelta flavescens Korth. is a liana plant from Rubiaceae family. 
In Kalimantan, it is known as Akar Tambolekar or Akar Merung [1] 
or Akar Manuran [2]. It is used in ethnobotany as herbs to overcome 
cough and shortness of breath [3]. Shortness of breath is a clinical 
symptom of bronchoconstriction that occurs in people with asthma or 
chronic obstructive pulmonary disease [4,5]. Therefore, it is presumed 
that C. flavescens Korth. root (CFR) has bronchorelaxation effect by 
relaxing the contracting bronchial smooth muscles. In a previously 
unpublished study, it has been shown that the CFRs methanol extract 
(MECFR) has a bronchorelaxation effect through the stimulation of the 
beta-2 adrenergic receptors. It has been known that MECFR contains 
secondary metabolites of saponins, polyphenols, triterpenoids, 
steroids, and anthraquinone; CFRs hexane fraction (HFCFR) contains 
anthraquinone and steroids; CFRs ethyl acetate fraction (EAFCFR) 
contains polyphenols, terpenoids, and anthraquinone; and CFRs 
methanol fraction (MFCFR) contains saponins, polyphenols, and 
terpenoids [6]. Secondary metabolites in plants contribute to the plants’ 
pharmacological effects [7]. Thus, the secondary metabolites in CFR 
which are responsible for CFRs bronchorelaxation effect can be found 
by studying the bronchorelaxation effect of different CFR’s fractions. 
While there were existing studies on MECFR bronchorelaxation effect 
on guinea pig’s bronchial ring precontracted with methacholine, there 
are no data available on the bronchorelaxation effect of any CFRs 
fraction, whether polar or non-polar. Therefore, the aim of this study 
was to compare the bronchorelaxation effect of MECFR with CFRs 
hexane (non-polar) fraction, CFRs ethyl acetate (semi-polar) fraction, 
and CFRs methanol (polar) fraction. The study was conducted using the 
isolated bronchial ring of guinea pigs [8].
MATERIALS AND METHODS
Materials
C. flavescens Korth. roots (CFRs) were collected from Paser Regency of 
East Kalimantan Province. Identification was done by the taxonomist of 
the Forestry Faculty of Mulawarman University with an identification 
letter no. 09/UN17.4.3.08/LL/2014. The roots were sorted and washed 
in running water then cut into small pieces and dried in an oven at 60°C 
until the water content was <10%, then ground into powder. Methanol, 
n-hexane, and ethyl acetate for extraction were purchased from Sigma-
Aldrich distributor in Surabaya. Ingredients to make Krebs-Henseleit 
solution such as NaCl, KCl, MgSO4, Na2HPO4, KH2PO4, CaCl2, and glucose 
were purchased from a distributor in Surabaya. Carbogen gas (95% 
O2 gas and 5% CO2 gas) was purchased from PT Murni Gas Raya in 
Samarinda.
Test animals were 3–4-month-old male guinea pigs weighing 350–
400 g obtained from Pharmacology Laboratory, Faculty of Medicine 
of Mulawarman University, Samarinda; ethical approval was obtained 
from Medical Ethics Committee, Faculty of Medicine of Mulawarman 
University.
Tools for bronchorelaxation assay were six chambers isolated organ 
bath, octal bridge amplifier, Power Lab/16SP digital recorder, isometric 
transducer, pH meter, tweezers, and surgical scissors.
Preparation of MECFR
Dried and ground simplicia of CFR (300 g) were macerated in 1.5 l of pro-
analytic methanol solution and shaken continuously for 3 day. The filtrate 
was collected and the residue was macerated further in pro-analytic 
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methanol solution. This procedure was repeated until the resulting filtrate 
became colorless. All the collected filtrates were then evaporated using a 
50°C vacuum rotavapor. The condensed mass obtained was heated in an 
oven (50°C) to obtain a dry extract with a moisture content of <10%.
Preparation of hexane, ethyl acetate, and methanol fractions of CFR
The CFR fractions were made using the same procedure as with 
MECFR, in a successive manner [9] by first using the non-polar solvent 
n-hexane. The concentrated extract obtained from the n-hexane filtrate 
was the HFCFR. The residue subsequently was aerated in the open air 
for 24 h to evaporate out the remaining n-hexane. Second, the semi-
polar solvent ethyl acetate was added using the same procedure as 
above. The concentrate obtained from the ethyl acetate filtrate was 
the EAFCFR. The residue was then aerated in the open air to evaporate 
out the remaining ethyl acetate solvent, and subsequently, the polar 
solvent methanol was added according to the above procedure. The 
concentrated extract obtained from the methanol filtrate with water 
content < 10% was the MFCFR. Each of the MECFR, HFCFR, EAFCFR, 
and MFCFR was weighed to calculate their yields.
Guinea pig’s bronchial preparation
Male guinea pigs (Cavia porcellus), 3–4 months old (350–400 g), were 
fasted for 12 h and subsequently anesthetized and sacrificed by cervical 
dislocation. Surgery was done by opening the abdomen and thorax until 
the lungs were visible. After dissecting the lungs and trachea, they were 
placed in a Petri dish containing Krebs-Henseleit solution. Attached fats 
and connective tissue were removed from the bronchial segments, and it 
was then cut into a length of 4 mm and put into an organ bath filled with 
10 ml Krebs-Henseleit solution, maintained at 37°C, pH 7.4, and flooded 
with carbogen gas. Bronchial ring arrangement was in accordance with 
what has been described by Albuqueque [8]. One end of the bronchial 
ring was connected with a stainless steel tissue holder and the other end 
was mounted on an isometric transducer with a tone of 1 g and connected 
to a Power Lab recording device, AD Instrument with Program Chart v.5. 
Changes in bronchial contractility on the computer were recorded in g.
Bronchorelaxation effect of MECFR on bronchial ring assay
Before treatment, the bronchial ring was equilibrated in Krebs-Henseleit 
solution for 60 min, and every 15 min, the solution was replaced with 
fresh solution. After the equilibrium state had been achieved, single dose 
amounted to 20 µl of 10−3 M methacholine solution was administered 
and maximum contraction was reached. After plateau had been 
reached, the extract solvent 10% dimethyl sulfoxide (DMSO) ethanol 
was given cumulatively in increasing dosages every 100 s and then left 
undisturbed for 10 min. Subsequently, the solution was replaced with new 
Krebs-Henseleit solution for 3 times every 10 min. The treatment was 
continued again with precontraction using a single dose of 20 µl of 10−3 M 
methacholine solution until the maximum contraction was reached, and 
then, MECFR solution was given cumulatively in increasing dosages of six 
different concentrations every 100 s and then left undisturbed for 10 min.
Bronchorelaxation effect of HFCFR, EAFCFR, and MFCFR on 
bronchial ring assays
The procedure for the bronchorelaxation effect assay for each HFCFR, 
EAFCFR, and MFCFR was similar with the bronchorelaxation effect 
assay for MECFR on the isolated bronchial ring of guinea pig which was 
contracted with methacholine, using 10% DMSO ethanol solvent as the 
negative control (NC).
Calculation of the percentage of relaxation
The bronchial ring’s percent of relaxation was calculated using the 
following equation:
   
( ) ( )
( )
−Relaxation response g response of NC g
% Relaxation =  × 100
Max precontration response g
Then, the dose-response curve (DRC) was made by plotting the negative 
log of extract or fraction concentration on X-axis and bronchial ring’s 
percentage of relaxation on Y-axis. The maximum efficacy (Emax) was 
obtained from the maximum percentage of relaxation.
Statistical analysis
The data obtained were presented in the mean ± standard error of the 
mean (sem). Percentage of relaxation from all six concentrations and 
Emax from the DRC of MECFR, HFCFR, EAFCFR, MFCFR, and NC were 
analyzed with Sigma plot 12.5 one-way ANOVA, followed by the Tukey 
test. p=0.05 or less was considered to be statistically significant.
RESULTS
Yield from methanol extract, hexane fraction, ethyl acetate fraction 
and methanol fraction of CFR
Table 1 shows the MECFR yield from 300 g of CFR simplicia and HFCFR, 
EAFCFR, and MFCFR yield from 667 g of CFR simplicia. The largest 
yield was obtained from MECFR (21.94%), while the least yield was 
from hexane fraction (HFCFR) and ethyl acetate fraction (EAFCFR) at 
only 4%.
Bronchorelaxation effect of MFCFR, EAFCFR, HFCFR, and MECFR on 
guinea pig’s bronchial rings precontracted with methacholine
Fig. 1 shows the relaxation effect on bronchial rings precontracted with 
2 µM of methacholine; then, each was given MFCFR, EAFCFR, HFCFR, 
MECFR, and the extract’s solvent, 10% DMSO ethanol, at cumulative 
doses. DRC of MFCFR, EAFCFR, HFCFR, and MECFR on Fig. 1 showed 
that as the concentration of extract or fractions became larger, the 
bronchial ring’s percentage of relaxation increased. The percentage 
of relaxation for each of the fractions and extract was larger and 
significantly different (p<0.05*) when compared to the NC, the extract’s 
solvent; this showed that MFCFR, EAFCFR, HFCFR, and MECFR had 
bronchorelaxation effect and they were not influenced by the extract’s 
solvent.
Fig. 1 also shows the maximum efficacy (Emax) of MFCFR, EAFCFR, 
HFCFR, and MECFR. The Emax of MFCFR (−136.63±14.31%) was not 
significantly different (p>0.05) compared with the Emax of MECFR 
(−146.48±21.03%). The Emax of EAFCFR (−76.74±4.68%) and HFCFR 
(−80.01±6.68%) was smaller and significantly different compared with 
the Emax of MECFR with p<0.05**. The Emax of EAFCFR was similar to the 
Emax of HFCFR (p>0.05). This showed that the bronchorelaxation effect 
of EAFCFR and HFCFR was similar but were weaker compared with 
MECFR and MFCFR. It could also be interpreted that among the extract 
and fractions, the bronchorelaxation activity of MECFR and MFCFR was 
the strongest.
DISCUSSION
The study’s result shows that the bronchorelaxation effect of MECFR 
and MFCFR is of similar strength. In another unpublished study, 
MECFR has bronchorelaxation effect through stimulation of the 
beta-2 adrenergic receptors; MECFR acts as beta-2 agonist which 
stimulates beta-2 adrenoceptors which are part of the G-protein-
coupled receptors group with Gs alpha subunit. Beta-2 adrenoceptor 
coupled with Gs protein stimulates adenylyl cyclase and produces 
second messenger cyclic adenosine monophosphate (cAMP) [10]. In 
the airways, cAMP will reduce intracellular Ca2+ concentration and 
activates protein kinase A resulting in the inactivation of myosin light-
chain kinase (MLCK) and activation of ML-chain phosphatase (MLCP). 
MLCP activation will prevent the binding of actin and myosin which 
leads to smooth muscle relaxation. The decrease in intracellular Ca2+ 
Table 1: Yield from CFR extract and fractions






Asian J Pharm Clin Res, Vol 12, Issue 4, 2019, 94-97
 Kosala et al. 
concentrations also causes a reduction in Ca-calmodulin binding such 
that contraction does not occur [11,12,13]. Other mechanisms that can 
affect bronchorelaxation are non-adrenergic non-cholinergic receptor 
pathway inhibitor, calcium channel antagonist, potassium channel 
activator, and epithelium-derived relaxing factors such as nitrite oxide 
and prostaglandin E2 [13,14].
Research’s result also shows that MECFR and MFCFR have stronger 
bronchorelaxation effect on bronchial ring precontracted with 
methacholine, compared with HFCFR and EAFCFR. This result 
correlates with the active compound or secondary metabolite content 
in each extract and fraction. It has been known that MFCFR contains 
polyphenol, terpenoid, and saponin; EAFCFR contains polyphenol, 
terpenoid, and anthraquinone; and HFCFR contains steroids and 
anthraquinone [6,15]. From other researches, it has been shown that 
polyphenol, terpenoid, saponin, and steroid in other plant’s extracts 
have some effects on the receptor related to the airway smooth muscle 
relaxation. Examples are as follows: Thymoquinone, a terpenoid 
widely contained in the essential oil of Nigella sativa, protects guinea 
pigs against histamine-induced bronchospasm. The water extract of 
N. sativa relaxes the tracheal smooth muscle of guinea pig through 
beta-2 adrenoceptor stimulation [16]. ɣ-sitosterol, found in Mimosa 
pudica L., can relax the smooth muscles of histamine-induced tracheal 
rings of a guinea pig [17]. Quercetin, a polyphenol (flavonoid group) 
which is found abundantly in fruits and vegetables, has been reported 
to have relaxation effects on human’s bronchial smooth muscle through 
the inhibition of acetylcholine and histamine-induced bronchial 
contraction. It also has effects in the relaxation of guinea pig’s bronchus 
by increasing the rate of cAMP formation such that cAMP-dependent 
protein kinase is activated and inhibits MLCK through phosphorylation, 
resulting in the reduction in contraction [7].
There are other studies which have shown plant extracts containing 
other secondary metabolites in the presence of either polyphenol, 
terpenoid, saponin, or steroid, having the effect of relaxing airway 
smooth muscle such as the raw extracts of Spinacia oleracea L. seeds 
which contain phenol, saponin, steroid, and tannin compounds 
have bronchodilation effect on rabbit trachea samples which were 
contracted with carbachol and high dosages of K+ [18]. The ethanol 
extracts of Limonia acidissima Linn. pulp which contain flavonoids, 
glycosides, saponins, tannins, alkaloids, polyphenol, and sterols have 
bronchodilatory and antiasthmatic effect on the tracheal chains of 
guinea pig [19]. Marmin, a coumarin derivative isolated from stem 
bark and the root of Aegle marmelos Corr., has the effect to inhibit the 
guinea pig tracheal chain contraction induced by a series of histamine 
concentration in a competitive manner [20]. The stem of Albizia lebbeck 
Benth., Fabaceae, which contains tannin, catechin, triterpenoid, and 
albiziasaponin A, B, and C, has activities in the protection against 
histamine- and acetylcholine-induced bronchoconstriction on some 
of the test animal models, as they have exhibited relaxation of smooth 
muscles, antihistamine, and antispasmodic activities. The extract of 
Balanite saegyptiaca Delile. and Zygophyllaceae (Balanitaceae) fruits, 
which contains steroidal saponin, coumarin, organic acid, balagyptin, 
balanitin-3 (spirostanol glycoside), balanitin-6 and 7, and other 
diosgenyl saponin and flavonoid, exhibits bronchodilation effect due to 
the presence of steroidal saponin [21].
Therefore, similarly applied to this research, the secondary metabolite 
in MECFR such as polyphenol, saponin, triterpenoid, and steroid 
has bronchorelaxation activities. The difference in strength of 
bronchorelaxation effects shown by the MFCFR, EAFCFR, and HFCFR 
could be affected by the type and quantity of the secondary metabolites 
in each fraction. From the extraction and fractionation result, EAFCFR 
and HFCFR yield were the smallest at only 4% while MFCFR yield 
was 11.9% and MECFR has the highest yield at 21.9% (Table 1). 
Consequently, the quantities of secondary metabolites in the EAFCFR 
and HFCFR were lower compared with MFCFR and MECFR which also 
can affect bronchorelaxation effect.
Polyphenol, saponin, and terpenoid are similar types of the secondary 
metabolites within MFCFR and MECFR which have stronger 
bronchorelaxation effect than EAFCFR and HFCFR. Therefore, it can be 
postulated that the secondary metabolites in CFR responsible for the 
bronchorelaxation effects are polyphenol, saponin, and terpenoid.
CONCLUSION
The bronchorelaxation effect of the MECFR on guinea pig’s bronchial 
ring is of similar strength with its methanol fraction and of higher 
efficacy than its ethyl acetate fraction and hexane fraction.
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